Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003756959 | SCV004532776 | pathogenic | RYR1-related disorder | 2022-12-29 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with RYR1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu2157Serfs*22) in the RYR1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RYR1 are known to be pathogenic (PMID: 20583297, 20839240, 23919265, 28818389). |
All of Us Research Program, |
RCV004005879 | SCV004827009 | uncertain significance | Malignant hyperthermia, susceptibility to, 1 | 2023-05-04 | criteria provided, single submitter | clinical testing | |
Human Genome Sequencing Center Clinical Lab, |
RCV004556877 | SCV005045726 | likely pathogenic | Congenital multicore myopathy with external ophthalmoplegia | 2021-07-19 | criteria provided, single submitter | clinical testing |